Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
At Luminus Izivia EVCS, were expanding one of Belgiums fastest-growing public fast-charging networks for electric vehicles. As a joint venture between Luminus and IZIVIA (part of the EDF Group), were helping accelerate the energy transition by making